Four Potential Suitors for Onyx Pharmaceuticals, Inc. (ONXX)
The "people familiar with the matter" are out in full force spouting off about who's bidding for Onyx Pharmaceuticals, Inc.
Posts Tagged ‘Gilead Sciences Inc (GILD)’
Gilead Sciences, Inc. (GILD), AbbVie Inc (ABBV): Which Company Needs a HCV Win?
The upcoming all-oral hepatitis C treatments earned well-deserved attention for some staggering cure rates, particularly in patient groups who haven’t responded well to the ...
Biogen Idec Inc. (BIIB), Celgene Corporation (CELG), Gilead Sciences, Inc. (GILD): 3 of Biotech’s Best
It’s been a healthy year-to-date for the biotech sector, with the space logging huge gains above and beyond those of the broad based market.
Abbott Laboratories (ABT), AbbVie Inc (ABBV): Why Investors Should Care About Hepatitis C
Hepatitis C, caused by the hepatitis C virus (HCV), is an infectious disease affecting the liver.
Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ): Is a Breakthrough Treatment on the Way for People With HIV?
We as a country have a come a long way over the past two decades with regard to treating HIV and reducing the number of AIDS diagnoses.
Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN): Is This A Good Acquisition For All?
For the second day in a row, the hot topic in the market is the bidding war for Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX). After rejecting Amgen, Inc.
Onyx Pharmaceuticals, Inc. (ONXX) Bidding Wars: Who Would Be the Best Suitor?
Recently, Amgen, Inc. (NASDAQ:AMGN) made a surprisingly low offer to acquire the pharmaceutical company Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX).
Three Things That Will Move AbbVie Inc (ABBV) Stock
AbbVie Inc (NYSE:ABBV) has risen more than 20% since it hit the market earlier this year. In fact, it has managed to beat the S&P 500 by nearly 10%.
Amazon.com, Inc. (AMZN), Siemens AG (ADR) (SI): Why You Should Consider These Three Stocks
Stock price movements reflect investors' opinions about a company's worth; upward moves attracts investor interest because they indicates good performance.
Johnson & Johnson (JNJ) Stock Is Always a Buy (If You Hold Long Enough)
To prove my point, I looked at the multi-year chart and picked out some of the peaks.
Idenix Pharmaceuticals Inc (IDIX), Bristol Myers Squibb Co. (BMY): The Most Unlucky Biotech in the World
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) just can't catch a break.
VIVUS, Inc. (VVUS), ISIS Pharmaceuticals, Inc. (ISIS), Gilead Sciences, Inc. (GILD): Biotech Companies Battle It Out
Biotech companies sometimes get lucky, launching a drug into a new indication where there's no competition, but more often than not the biotech companies have to battle it out...
Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG): Biting Into Biotechnology
Global equity markets have been rocked recently as fears of rising interest rates and tightening monetary possible make their way into the minds of the street.
Amgen, Inc. (AMGN): The Only True Biotech Dividend Stock
Dividend stocks are hard to come by in the biotech space.
Gilead Sciences, Inc. (GILD): This Biotech Leader Is Poised to Outperform
Investing in biotech companies can be risky; developing new drugs is a long, expensive, and uncertain process, and there is always considerable regulatory risk in the industry...
AbbVie Inc (ABBV) Has Much More Upside Reward Than Downside Risk
For investors viewing AbbVie Inc (NYSE:ABBV) as a value play since its spin-off from Abbott Laboratories (NYSE:ABT), it is time to think again.
Gilead Sciences, Inc. (GILD), Siemens AG (SI) & Amazon.com, Inc. (AMZN): Three Companies With Solid EPS Growth
Earnings Per Share (EPS) growth is one measure of a company's profitability. Since it is often the most commonly discussed performance metric, it tends to drive share prices.
Abbott Laboratories (ABT), AbbVie Inc (ABBV): This FDA Approval Is Exciting News for Hepatitis-C Patients
Hepatitis-C is a contagious virus that attacks the liver and can be found in acute or chronic forms.
Gilead Sciences, Inc. (GILD), Bristol Myers Squibb Co. (BMY): The Best Healthcare Bet
Gilead Sciences, Inc. (NASDAQ:GILD) has been one of the most prolific investments in the healthcare sector.
Amgen, Inc. (AMGN): Huge Upside on Pipeline Strength
Amgen, Inc. (NASDAQ:AMGN) is the world’s largest independent biotechnology company.
Gilead Sciences, Inc. (GILD), American International Group, Inc. (AIG): The Biggest Companies That Don’t Pay Dividends — But May Be About To
The S&P 500 fell nearly 10% in June 2008, and investors began to brace for an eventual market crash later in the year.
Gilead Sciences, Inc. (GILD): Three Key Advances in HIV Prevention
According to the World Health Organization, there are 34 million HIV-positive individuals in the world today, and the virus has claimed the lives of 25 million people since the...
Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG): Thursday’s Top Upgrades (and Downgrades)
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on.
Brahman Capital Owns 5.7% of Endo Health Solutions Inc (ENDP)
A 13G filed with the SEC has disclosed that Brahman Capital, a hedge fund managed by Peter Hochfelder and his team, owns 6.3 million shares of Endo Health Solutions Inc (NASDAQ...
Johnson & Johnson (JNJ), Vertex Pharmaceuticals Incorporated (VRTX): Inside HCV, An Interview with Janssen
Our job here is to examine companies through an investing perspective.
Rigel Pharmaceuticals, Inc. (RIGL), Synta Pharmaceuticals Corp. (SNTA): Three Horrendous Health-Care Stocks This Week
Many stocks encountered turbulence this week, but few were blown about like several biotech stocks.
Gilead Sciences, Inc. (GILD)’s Entry Into Cancer Therapy
It is interesting to watch a bio company change tactics and go into an area it hasn't explored before. This, to me, is like watching a child suddenly grow up.
Merck & Co., Inc. (MRK), Clovis Oncology Inc (CLVS), Regulus Therapeutics Inc (RGLS): 3 Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Where to Invest for More Health-Care Exposure
You have plenty of choices of where to invest your portfolio.
Regeneron Pharmaceuticals Inc (REGN), Amgen, Inc. (AMGN), Gilead Sciences, Inc. (GILD): Is College Debt a Drag on These Promising Healthcare Stocks
Some stocks seem to have all the luck, offering the best of both worlds.
Johnson & Johnson (JNJ) Takes a Breather
After a 12-week run of seeing its share price rise for the week, Johnson & Johnson (NYSE:JNJ) stock fell last week.
Bristol Myers Squibb Co. (BMY), Gilead Sciences, Inc. (GILD), Halozyme Therapeutics, Inc. (HALO): 3 Stocks to Watch Ahead of ASCO
At the annual ASCO meeting in Chicago, thousands of health-care researchers and professionals unite to advance cancer treatment.
Amgen, Inc. (AMGN): The Ultimate Biotech Diversification Strategy
You want to invest in biotech. You hear about all the monstrous pops and mini-fortunes that are built overnight.
Amgen, Inc. (AMGN) Stock Checkup for May
I have jokingly referred to Amgen, Inc. (NASDAQ:AMGN) in the past as a "senior citizen" of biotech. The company was founded 33 years ago, making Amgen, Inc.
Johnson & Johnson (JNJ), Gilead Sciences, Inc. (GILD), AbbVie Inc (ABBV): Watch This HCV Player
Johnson & Johnson (NYSE:JNJ)'s hepatitis C drug, simeprevir, recently received Priority Review status from the FDA.
Bristol Myers Squibb Co. (BMY), Pharmacyclics, Inc. (PCYC): Hedging Against Leukemia
As I noted 11 weeks ago, cancer statistics are both staggering and disappointing.
Infinity Pharmaceuticals Inc. (INFI), Oncothyreon Inc (USA) (ONTY), Synageva BioPharma Corp (GEVA): Three Horrendous Healthcare Stocks This Week
There's one drawback to having the stock market indexes hit record highs yet again: It makes finding truly horrendous health-care stocks for our weekly series much more challenging...
Roche Holding Ltd. (ADR) (RHHBY), Bristol Myers Squibb Co. (BMY): Cancer Meeting Highlights the Good and Bad of the Immune System
Biotech investors rejoice. The ASCO abstracts are here.
Is Gilead Sciences, Inc. (GILD) Still A Buy?
Gilead Sciences, Inc. (NASDAQ:GILD) reported a relatively rare earnings miss in the first quarter on May 2.
UnitedHealth Group Inc. (UNH), Aetna Inc. (AET): The Eight Biggest Health Problems Americans Face
The Centers for Disease Control and Prevention would put heart disease at the top of the list, since it's the leading cause of death in the nation.
Vertex Pharmaceuticals Incorporated (VRTX): What You Need To Know
What's the source of your investment strategy? Many look to great investors like Warren Buffett for guidance on how to invest.
Gilead Sciences, Inc. (GILD): The Heart Of The Matter
Gilead Sciences, Inc. (NASDAQ:GILD) has exploded over the last few years as a powerhouse of anti-viral medications. Its myriad treatments for HIV have brought in $2 billion...
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY) & Other Names To Know: A Full Breakdown
Investing in biotech companies can be intimidating, especially for investors without a science background. But there's hope.
Gilead Sciences, Inc. (GILD), Interactive Brokers Group, Inc. (IBKR): Should You Bet on These High-Growth Stocks?
Proponents of income investing may not like it, but there is nothing like a growth portfolio, portions of which can be sold at higher prices to rival the benefits of a dividend...
Vertex Pharmaceuticals Incorporated (VRTX) Just Jumped & Could Jump Again
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) have appreciated significantly in 2013 so far, and it seems that the trend might continue for the rest of the year.
Galena Biopharma Inc (GALE), Gilead Sciences, Inc. (GILD): Two Biopharmaceutical Companies Worth Buying
The biotechnology industry had a good time last year and the market expects the trend to continue in 2013 as well.
Celgene Corporation (CELG), Biogen Idec Inc. (BIIB), Gilead Sciences, Inc. (GILD): Don’t Try to Pick the Best Biotech Company
Rising biotech stars Celgene Corporation (NASDAQ:CELG), Biogen Idec Inc. (NASDAQ:BIIB), and Gilead Sciences, Inc.
Microsoft Corporation (MSFT) Weekly Options Active
Microsoft Corporation (NASDAQ:MSFT) – Reporting from CNBC’s David Faber this morning that activist fund ValueAct Capital Management LLC has acquired a $2 billion stake in...
Gilead Sciences, Inc. (GILD) or Biogen Idec Inc. (BIIB)? This Is What the Perfect Biotech Would Look Like
I don't know about you, but I'm pretty stoked for the NFL draft this Thursday.
Gilead Sciences, Inc. (GILD), Visa Inc (V), High-Momentum Stocks, Dividends, and Low Fees
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.
